A01=Robert A. Freitas
advanced materials science
artificial cell interaction
ATP Release
Author_Robert A. Freitas
biomedical engineering
C3 Convertase
Carbon Fiber
Category=PS
Category=PSF
Class Ii
Class II396
CVD Diamond
cytotoxicity assessment
Degradable Starch Microspheres
Diamond Dust
Diamond Surfaces
DLC Coating
DNA Dendrimer Complex
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
Foreign Body Giant Cells
human tissue response to nanodevices
immunological response
Kupffer Cells
Laminar Flow Clean Rooms
Medical Nanorobots
nanotechnology safety
Polystyrene Microspheres
Principal Toxic Component
Purkinje Neurons
Pyrolytic Carbon
Retinal Pigment Epithelial Lipofuscin
SEM 200X
Single Crystal Sapphire
Spherical Cell Shape
Synthetic Vitreous Fibers
White Cells
Product details
- ISBN 9781570597008
- Weight: 680g
- Dimensions: 210 x 280mm
- Publication Date: 26 Sep 2003
- Publisher: Taylor & Francis Inc
- Publication City/Country: US
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
The safety, effectiveness, and utility of medical nanorobotic devices will critically depend upon their biocompatibility with human organs, tissues, cells, and biochemical systems. In this Volume, we broaden the definition of nanomedical biocompatibility to include all of the mechanical, physiological, immunological, cytological, and biochemical responses of the human body to the introduction of artificial medical nanodevices, whether “particulate” (large doses of independent micron-sized individual nanorobots) or “bulk” (nanorobotic organs assembled either as solid objects or built up from trillions of smaller artificial cells or docked nanorobots inside the body) in form.
Robert A. Freitas, Research Scientist, Zyvex Corporation, Richardson, Texas, U.S.A.
